Guiding Breakthrough Scientific Achievement

ViaCtye’s Clinical Advisors ensure that the Company’s scientific and clinical initiatives in stem cell therapy are best-in-class.

ViaCyte is creating, in a sense, a biological artificial pancreas from human stem cells and proprietary encapsulation technology

Howard Foyt, M.D., Ph.D., FACP, Chief Medical Officer, ViaCyte

Jeffrey A. Bluestone, Ph.D.

Director, UCSF Diabetes Center, University of California, San Francisco

Orville G. Kolterman, M.D.

Former Senior Vice President & Chief Medical Officer, Amylin Pharmaceuticals

James Shapiro, M.D., Ph.D.

Director, Clinical Islet Transplant Program, University of Alberta, Canada

Daniel Pipeleers M.D., Ph.D.

Director, Diabetes Research Center, Free University of Brussels, Belgium

Jay S. Skyler , M.D.,

Professor of Medicine, Pediatrics and Psychology, University of Miami Miller School of Medicine and Associate Director for Academic Programs at the Diabetes Research Institute